The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

PURPOSE: To demonstrate the safety and feasibility of the Urocross Expander System (formerly branded as XFLO Expander System), an implantable nitinol tissue expander to trea t patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: Men of 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Henry H., Huang, Chi-Ping, Huang, William J., Chang, Yi-Huei, Lien, Chi-Shun, Chkhotua, Archil, Elterman, Dean S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385491/
https://www.ncbi.nlm.nih.gov/pubmed/35641601
http://dx.doi.org/10.1038/s41391-022-00548-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385491/
https://www.ncbi.nlm.nih.gov/pubmed/35641601
http://dx.doi.org/10.1038/s41391-022-00548-z

Ejemplares similares